To apply for the Accretion Pharmaceuticals IPO, investors can log in to their trading accounts via their respective brokers and navigate to the IPO section. From there, they must select "Accretion Pharmaceuticals IPO," enter the number of lots (minimum 1200 shares), choose the bid price within the ₹96–₹101 range, and submit their UPI ID for payment. Ensure the UPI mandate is approved by 5 PM on May 16, 2025. To check the allotment status, applicants can visit the registrar’s website—Kfin Technologies Limited—after the tentative allotment date of May 19, 2025, and enter their application details such as PAN, DP ID, or application number to view the status.
For complete details on this public offering, visit the Accretion Pharmaceuticals IPO page on Bajaj Broking’s website.
Accretion Pharmaceuticals IPO Application Process
The Accretion Pharmaceuticals IPO application process can be completed online through your trading platform. Below is a step-by-step guide to applying for the IPO:
Step 1: Login to Your Trading Platform
Access your trading account using Bajaj Broking’s app or website.
Step 2: Navigate to the IPO Section
Go to the IPO section to view active IPO listings.
Step 3: Select the Open IPO and Click Apply
Locate Accretion Pharmaceuticals IPO in the list of available IPOs and click the ‘Apply’ button.
Step 4: Enter the Quantity of Shares You Wish to Apply For
Specify the number of shares (minimum lot size: 1200 shares) within the price band of ₹96 to ₹101 per share.
Step 5: Provide Your UPI ID
Enter your UPI ID for payment authorization and ensure sufficient funds in your bank account.
Step 6: Confirm the Application
Review your application details and confirm the UPI mandate before 5 PM on the last application day.
Step 7: Complete the Process and Wait for Allotment
Submit the application and monitor the allotment status to check if shares have been allocated to you.
How to Check Accretion Pharmaceuticals IPO Allotment Status?
Once the allotment for Accretion Pharmaceuticals IPO is finalized, investors can check their status online using the following steps:
Step 1: Visit the Official Website of the IPO's Registrar
Access the registrar’s portal for allotment status updates.
Step 2: Navigate to the IPO Allotment Status Page
Locate the specific section for IPO allotment on the website.
Step 3: Enter Your PAN Number, Demat ID, or Application Number
Provide the necessary details to retrieve your application status.
Step 4: Click on 'Submit' or 'Check Status'
Verify the allotment details displayed on the screen.
Step 5: Alternative Check on Stock Exchange Websites
Visit SME or NSE websites and follow the IPO allotment instructions.
Step 6: Check via Bajaj Broking Website
Log in to Bajaj Broking, access the IPO section, and view your allotment updates in the IPO Allotment Status.
About Accretion Pharmaceuticals IPO: Overview and Key Facts
Accretion Pharmaceuticals Limited, established in 2012, is a pharmaceutical company based in Sanand, Ahmedabad, Gujarat. The company specializes in the manufacturing and marketing of a diverse range of healthcare products, including tablets, capsules, oral liquids, oral powders (such as sachets and dry syrups), and external preparations like ointments, creams, gels, lotions, medicated shampoos, mouthwash, and dusting powders. In addition to direct sales, Accretion Pharmaceuticals offers contract and loan license manufacturing services to various third-party marketers, operating primarily on a principal-to-principal basis. The company's manufacturing facility is ISO 9001:2015, ISO 14001:2015, and ISO 22000:2018 certified, reflecting its adherence to quality, safety, and environmental standards.
The Initial Public Offering (IPO) of Accretion Pharmaceuticals is scheduled to open for subscription from May 14 to May 16, 2025. The IPO comprises a fresh issue of 29,46,000 equity shares, aggregating up to ₹29.75 crore. The price band for the IPO is set between ₹96 to ₹101 per share, with a minimum lot size of 1,200 shares. The shares are proposed to be listed on the NSE SME platform. The lead manager for the issue is Jawa Capital Services Private Limited, and the registrar is KFin Technologies Limited. The market maker for the IPO is Gretex Share Broking Private Limited.
The proceeds from the IPO are intended to be utilized for capital expenditure towards the purchase of new equipment and machinery, upgradation of the existing manufacturing facility, repayment or prepayment of certain borrowings, funding working capital requirements, and general corporate purposes. This strategic move aims to enhance the company's operational capabilities and support its growth initiatives. Investors interested in applying for the IPO can do so through their trading accounts by navigating to the IPO section, selecting "Accretion Pharmaceuticals IPO," entering the required details, and completing the application process using UPI or ASBA payment methods.
To check your application status, visit the Accretion Pharmaceuticals IPO Allotment Status page on Bajaj Broking’s website.